Edoxaban in Atrial Fibrillation and Venous Thromboembolism—Ten Key Questions and Answers: A Practical Guide

Edoxaban is the fourth non-vitamin K antagonist oral anticoagulant now available for clinical use in the prevention of stroke/systemic embolism in atrial fibrillation (AF) and in the treatment of venous thromboembolism (VTE), after the completion of large-scale randomized comparative clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales: De Caterina, Raffaele, Ageno, Walter, Boriani, Giuseppe, Colonna, Paolo, Ghirarduzzi, Angelo, Patti, Giuseppe, Rossini, Roberta, Rubboli, Andrea, Schinco, Piercarla, Agnelli, Giancarlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350200/
https://www.ncbi.nlm.nih.gov/pubmed/28194578
http://dx.doi.org/10.1007/s12325-017-0488-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350200/
https://www.ncbi.nlm.nih.gov/pubmed/28194578
http://dx.doi.org/10.1007/s12325-017-0488-9

Ejemplares similares